Skip to main content

Table 1 Basic clinical data of healthy people, CHB patients and ACLF patients

From: The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Groups

Normal people (n = 27)

CHB patients (n = 52)

ACLF patients (n = 145)

value

Age (years)

35 ± 15

38 ± 11

48 ± 12

0.095

Sex, male /female

19/8

38/14

116/29

0.085

INR

0.97 ± 0.09

1.15 ± 0.16

2.19 ± 0.79

 < 0.001

TBiL (μmol/L)

9.48(5.95–12.45)

145.89(42.4–222)

406.74(281.8–508.5)

 < 0.001

ALT (IU/L)

21(16–36)

220(90–856)

99(51–262)

0.001

ALB(g/L)

46.73 ± 4.51

36.98 ± 4.8

31.96 ± 3.46

 < 0.001

Cr (μmol/L)

74.14 ± 24.14

71.83 ± 12.43

87.88 ± 24.41

0.104

WBC(× 109/L)

6.99 ± 2.45

5.44 ± 1.69

7.12 ± 3.84

0.093

PLT(× 109/L)

195.6(119.5–245)

176.52(126–232)

95.23(58–126)

 < 0.001

AFP(ng/ml)

2.95(2.5–6)

39.42(4.74–116.69)

54.67(13.25–254.78)

 < 0.001